ARCHIVES

Blood Vessel Growth Inhibitor May Be Tested Against KS

This article is from The Cancer Letter archive.

Vol. 17 No. 33 | August 16, 1991

Download PDF Visit The Full Archive

Related Articles

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

House Appropriations by Institute

July 8, 1994

NCI CTEP Approved Trials For the Month of February

February 22, 2013

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program

September 5, 1975

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989